Zdrowie i gospodarka · 18/04/2017

FDA Hosts Public Workshop on Clinical Outcome Assessments in Cancer Clinical Trials

The FDA, in partnership with the Critical Path Institute's Patient-Reported Outcome Consortium, is hosting a public workshop to discuss challenges and opportunities in clinical outcome assessments, particularly patient-reported outcomes, in cancer drug development, with the goal of improving treatment decisions.